| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917893 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
PET scanning with [18F]HX4 was feasible in both EC and PC patients. Amount and location of elevated [18F]HX4 uptake showed good repeatability, suggesting [18F]HX4 PET could be a promising tool for radiation therapy planning and treatment response monitoring in EC and PC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![Feasibility and repeatability of PET with the hypoxia tracer [18F]HX4 in oesophageal and pancreatic cancer](/preview/png/10917893.png "First Page Preview: Feasibility and repeatability of PET with the hypoxia tracer [18F]HX4 in oesophageal and pancreatic cancer")
Authors
Remy Klaassen, Roelof J. Bennink, Geertjan van Tienhoven, Maarten F. Bijlsma, Marc G.H. Besselink, Mark I. van Berge Henegouwen, Johanna W. Wilmink, Aart J. Nederveen, Albert D. Windhorst, Maarten C.C.M. Hulshof, Hanneke W.M. van Laarhoven,